logo

Silver nanoparticles Synthesis medical applications safety

PDF Publication Title:

Silver nanoparticles Synthesis medical applications safety ( silver-nanoparticles-synthesis-medical-applications-safety )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 033

Theranostics 2020, Vol. 10, Issue 20 9028 159. Haseeb M, Khan MS, Baker A, Khan I, Wahid I, Jaabir MM. Anticancer and antibacterial potential of MDR Staphylococcus aureus mediated synthesized silver nanoparticles. Biosci Biotech Res Comm. 2019; 12: 26-35. 160. Zhang Y, Lu H, Yu D, Zhao D. AgNPs and Ag/C225 Exert Anticancerous Effects via Cell Cycle Regulation and Cytotoxicity Enhancement. J Nanomater. 2017; 2017: 1-10. 161. Yang T, Yao Q, Cao F, Liu Q, Liu B, Wang X-H. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis. Int J Nanomedicine. 2016; 11: 6679–6692. 162. Marsich E, Bellomo F, Turco G, Travan A, Donati I, Paoletti S. Nano-composite scaffolds for bone tissue engineering containing silver nanoparticles: preparation, characterization and biological properties. J Mater Sci Mater Med. 2013; 24: 1799-1807. 163. Chowdhury S, De M, Guha R, Batabyal S, Samanta I, Hazra SK, et al. Influence of silver nanoparticles on post-surgical wound healing following topical application. Eur J Nanomed. 2014; 237–247. 164. Salomoni R, Léo P, Rodrigues M. Antibacterial activity of silver nanoparticles (AgNPs) in Staphylococcus aureus and cytotoxicity effect in mammalian cells. substance. 2015; 851-857. 165. Paredes D, Ortiz C, Torres R. Synthesis, characterization, and evaluation of antibacterial effect of Ag nanoparticles against Escherichia coli O157: H7 and methicillin-resistant Staphylococcus aureus (MRSA). Int J Nanomedicine. 2014; 9: 1717–1729. 166. Salomoni R, Léo P, Montemor A, Rinaldi B, Rodrigues M. Antibacterial effect of silver nanoparticles in Pseudomonas aeruginosa. Nanotechnol Sci Appl. 2017; 10: 115–121. 167. Rónavári A, Igaz N, Gopisetty MK, Szerencsés B, Kovács D, Papp C, et al. Biosynthesized silver and gold nanoparticles are potent antimycotics against opportunistic pathogenic yeasts and dermatophytes. Int J Nanomedicine. 2018; 13: 695–703. 168. Kumar SD, Singaravelu G, Ajithkumar S, Murugan K, Nicoletti M, Benelli G. Mangrove-mediated green synthesis of silver nanoparticles with high HIV-1 reverse transcriptase inhibitory potential. J Clust Sci. 2017; 28: 359-367. 169. Sun RW-Y, Chen R, Chung NP-Y, Ho C-M, Lin C-LS, Che C-M. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun. 2005: 5059-5061. 170. Chatterjee T, Chatterjee BK, Majumdar D, Chakrabarti P. Antibacterial effect of silver nanoparticles and the modeling of bacterial growth kinetics using a modified Gompertz model. Biochim Biophys Acta Gen Subj. 2015; 1850: 299-306. 171. Raza M, Kanwal Z, Rauf A, Sabri A, Riaz S, Naseem S. Size-and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomaterials. 2016; 10.3390. 172. Agnihotri S, Mukherji S, Mukherji S. Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. Rsc Adv. 2014; 4: 3974-3983. 173. Jiraroj D, Tungasmita S, Tungasmita DN. Silver ions and silver nanoparticles in zeolite A composites for antibacterial activity. Powder Technol. 2014; 264: 418-422. 174. Hong X, Wen J, Xiong X, Hu Y. Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method. Environ Sci Pollut Res Int. 2016; 23: 4489-4497. 175. Mandal D, Dash SK, Das B, Chattopadhyay S, Ghosh T, Das D, et al. Bio-fabricated silver nanoparticles preferentially targets Gram positive depending on cell surface charge. Biomed Pharmacother. 2016; 83: 548-558. 176. van der Wal A, Norde W, Zehnder AJ, Lyklema J. Determination of the total charge in the cell walls of Gram-positive bacteria. Colloids Surf B Biointerfaces. 1997; 9: 81-100. 177. dos Santos CA, Jozala AF, Pessoa Jr A, Seckler MM. Antimicrobial effectiveness of silver nanoparticles co-stabilized by the bioactive copolymer pluronic F68. J Nanobiotechnology. 2012; 10: 43. 178. Lee K-J, Park S-H, Govarthanan M, Hwang P-H, Seo Y-S, Cho M, et al. Synthesis of silver nanoparticles using cow milk and their antifungal activity against phytopathogens. Mater Lett. 2013; 105: 128-131. 179. Mallmann EJJ, Cunha FA, Castro BN, Maciel AM, Menezes EA, Fechine PBA. Antifungal activity of silver nanoparticles obtained by green synthesis. Rev Inst Med Trop Sao Paulo. 2015; 57: 165-167. 180. Kim SW, Jung JH, Lamsal K, Kim YS, Min JS, Lee YS. Antifungal effects of silver nanoparticles (AgNPs) against various plant pathogenic fungi. Mycobiology. 2012; 40: 53-58. 181. Lu L, Sun R, Chen R, Hui C-K, Ho C-M, Luk JM, et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008; 13: 253-262. 182. Gaikwad S, Ingle A, Gade A, Rai M, Falanga A, Incoronato N, et al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomedicine. 2013; 8: 4303–4314. 183. Etemadzade M, Ghamarypour A, Zabihollahi R, Shirazi M, Sahebjamee H, Vaziri AZ, et al. Synthesis and evaluation of antiviral activities of novel sonochemical silver nanorods against HIV and HSV viruses. Asian Pac J Trop Dis. 2016; 6: 854-858. 184. Mori Y, Ono T, Miyahira Y, Nguyen VQ, Matsui T, Ishihara M. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett. 2013; 8: 93. 185. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology. 2005; 3: 6. 186. Pangestika R, Ernawati R. Antiviral Activity Effect of Silver Nanoparticles (Agnps) Solution Against the Growth of Infectious Bursal Disease Virus on Embryonated Chicken Eggs with Elisa Test. KnE Life Sciences. 2017; 3: 536-548. 187. Yun’an Qing LC, Li R, Liu G, Zhang Y, Tang X, Wang J, et al. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomedicine. 2018; 13: 3311-3327. 188. Wang L, Xu H, Gu L, Han T, Wang S, Meng F. Bioinspired synthesis, characterization and antibacterial activity of plant-mediated silver nanoparticles using purple sweet potato root extract. Materials Technology. 2016; 31: 437-442. 189. Radhakrishnan VS, Mudiam MKR, Kumar M, Dwivedi SP, Singh SP, Prasad T. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans). Int J Nanomedicine. 2018; 13: 2647–2663. 190. Sharma V, Kaushik S, Pandit P, Dhull D, Yadav JP, Kaushik S. Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Appl Microbiol Biotechnol. 2019; 103: 881-891. 191. Trefry JC, Wooley DP. Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J Biomed Nanotechnol. 2013; 9: 1624-1635. 192. Yang XX, Li CM, Huang CZ. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale. 2016; 8: 3040-3048. 193. Bharti B, Bharti S, Khurana S. Worm infestation: Diagnosis, treatment and prevention. Indian J Pediatr. 2018; 85: 1017-1024. 194. Taylor‐Robinson DC, Maayan N, Soares‐Weiser K, Donegan S, Garner P. Deworming drugs for soil‐transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance. Cochrane Database Syst Rev. 2015; 7: CD000371.. 195. Saha SK, Roy P, Saini P, Mondal MK, Chowdhury P, Babu SPS. Carbohydrate polymer inspired silver nanoparticles for filaricidal and mosquitocidal activities: A comprehensive view. Carbohydr Polym. 2016; 137: 390-401. 196. Saini P, Saha SK, Roy P, Chowdhury P, Babu SPS. Evidence of reactive oxygen species (ROS) mediated apoptosis in Setaria cervi induced by green silver nanoparticles from Acacia auriculiformis at a very low dose. Exp Parasitol. 2016; 160: 39-48. 197. Tomar R, Preet S. Evaluation of anthelmintic activity of biologically synthesized silver nanoparticles against the gastrointestinal nematode, Haemonchus contortus. J Helminthol. 2017; 91: 454-461. 198. Preet S, Tomar RS. Anthelmintic effect of biofabricated silver nanoparticles using Ziziphus jujuba leaf extract on nutritional status of Haemonchus contortus. Small Rumin Res. 2017; 154: 45-51. 199. Rashid MMO, Ferdous J, Banik S, Islam MR, Uddin AM, Robel FN. Anthelmintic activity of silver-extract nanoparticles synthesized from the combination of silver nanoparticles and M. charantia fruit extract. BMC Complement Altern Med. 2016; 16: 242. 200. Subarani S, Sabhanayakam S, Kamaraj C. Studies on the impact of biosynthesized silver nanoparticles (AgNPs) in relation to malaria and filariasis vector control against Anopheles stephensi Liston and Culex quinquefasciatus Say (Diptera: Culicidae). Parasitol Res. 2013; 112: 487-499. 201. McDaniel JT, Nuhu K, Ruiz J, Alorbi G. Social determinants of cancer incidence and mortality around the world: an ecological study. Glob Health Promot. 2019; 26: 41-49. 202. Pilleron S, Sarfati D, Janssen-Heijnen M, Vignat J, Ferlay J, Bray F, et al. Global cancer incidence in older adults, 2012 and 2035: A population-based study. Int J Cancer. 2019; 144: 49-58. 203. Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019; 54: 407-419. 204. Choudhury H, Pandey M, Yin TH, Kaur T, Jia GW, Tan SQL, et al. Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology. Mater Sci Eng C Mater Biol Appl. 2019; 101: 596-613. 205. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017; 17: 20-37. 206. da Silva PB, Machado RTA, Pironi AM, Alves RC, de Araújo PR, Dragalzew AC, et al. Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action-Review. Curr Med Chem. 2019; 2108-2146. 207. Machado R, Pironi A, Alves R, Dragalzew A, Dalberto I, Chorilli M. Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action-Review. Curr Med Chem. 2019; 26: 2108-2146. 208. Al-Sheddi ES, Farshori NN, Al-Oqail MM, Al-Massarani SM, Saquib Q, Wahab R, et al. Anticancer Potential of Green Synthesized Silver Nanoparticles Using Extract of Nepeta deflersiana against Human Cervical Cancer Cells (HeLA). Bioinorg Chem Appl. 2018; 9390784. 209. Gurunathan S, Qasim M, Park C, Yoo H, Kim JH, Hong K. Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in Human Colon Cancer Cells HCT116. Int J Mol Sci. 2018; 19: 2269. 210. Yuan YG, Peng QL, Gurunathan S. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment. Int J Nanomedicine. 2017; 12: 6487-6502. http://www.thno.org

PDF Image | Silver nanoparticles Synthesis medical applications safety

silver-nanoparticles-synthesis-medical-applications-safety-033

PDF Search Title:

Silver nanoparticles Synthesis medical applications safety

Original File Name Searched:

thnov10p8996.pdf

DIY PDF Search: Google It | Yahoo | Bing

Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info

Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info

All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info

CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info

Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info

Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info

Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.

Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.

CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP